Cargando…
Barriers to Lynch Syndrome Testing and Preoperative Result Availability in Early-onset Colorectal Cancer: A National Physician Survey Study
OBJECTIVE: Although widely recommended, Lynch syndrome (LS) testing with tumor microsatellite instability (MSI) and/or immunohistochemistry (IHC) is infrequently performed in early-onset colorectal cancer (CRC), and CRC generally. Reasons are poorly understood. Hence, we conducted a national survey...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148048/ https://www.ncbi.nlm.nih.gov/pubmed/30237431 http://dx.doi.org/10.1038/s41424-018-0047-y |
_version_ | 1783356687452733440 |
---|---|
author | Noll, Alan J. Parekh, Parth Zhou, Meijiao Weber, Thomas K. Ahnen, Dennis Wu, Xiao-Cheng Karlitz, Jordan J. |
author_facet | Noll, Alan J. Parekh, Parth Zhou, Meijiao Weber, Thomas K. Ahnen, Dennis Wu, Xiao-Cheng Karlitz, Jordan J. |
author_sort | Noll, Alan |
collection | PubMed |
description | OBJECTIVE: Although widely recommended, Lynch syndrome (LS) testing with tumor microsatellite instability (MSI) and/or immunohistochemistry (IHC) is infrequently performed in early-onset colorectal cancer (CRC), and CRC generally. Reasons are poorly understood. Hence, we conducted a national survey focusing on gastroenterologists, as they are frequently first to diagnose CRC, assessing testing barriers and which specialist is felt responsible for ordering MSI/IHC. Additionally, we assessed factors influencing timing of MSI/IHC ordering; testing on colonoscopy biopsy, opposed to post-operative surgical specimens, assists decisions on preoperative germline genetic testing and extent of colonic resection (ECR). METHODS: A 21-question web-based survey was distributed through an American College of Gastroenterology email listing. RESULTS: In total 509 completed the survey. 442 confirmed gastroenterologists were analyzed. Only 33.4% felt gastroenterologists were responsible for MSI/IHC ordering; pathologists were believed most responsible (38.6%). Cost, unfamiliarity interpreting results and unavailable genetic counseling most commonly prevented routine ordering (33.3%, 29.2%, 24.9%, respectively). In multivariable analysis, non-academic and rural settings were associated with cost and genetic counseling barriers. Only 46.1% felt MSI/IHC should always be performed on colonoscopy biopsy. Guideline familiarity predicted whether respondents felt surgical resection should be delayed until results returned given potential effect on ECR decisions. CONCLUSION: Inconsistencies in who is felt should order MSI/IHC may lead to diffusion of responsibility, preventing consistent testing, including preoperatively. Assuring institutional universal testing protocols are in place, with focus on timing of testing, can optimize care. Strategies addressing cost barriers and genomic service availability in rural and non-academic settings can enhance testing. Greater emphasis on guideline familiarity is required. |
format | Online Article Text |
id | pubmed-6148048 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-61480482018-09-21 Barriers to Lynch Syndrome Testing and Preoperative Result Availability in Early-onset Colorectal Cancer: A National Physician Survey Study Noll, Alan J. Parekh, Parth Zhou, Meijiao Weber, Thomas K. Ahnen, Dennis Wu, Xiao-Cheng Karlitz, Jordan J. Clin Transl Gastroenterol Article OBJECTIVE: Although widely recommended, Lynch syndrome (LS) testing with tumor microsatellite instability (MSI) and/or immunohistochemistry (IHC) is infrequently performed in early-onset colorectal cancer (CRC), and CRC generally. Reasons are poorly understood. Hence, we conducted a national survey focusing on gastroenterologists, as they are frequently first to diagnose CRC, assessing testing barriers and which specialist is felt responsible for ordering MSI/IHC. Additionally, we assessed factors influencing timing of MSI/IHC ordering; testing on colonoscopy biopsy, opposed to post-operative surgical specimens, assists decisions on preoperative germline genetic testing and extent of colonic resection (ECR). METHODS: A 21-question web-based survey was distributed through an American College of Gastroenterology email listing. RESULTS: In total 509 completed the survey. 442 confirmed gastroenterologists were analyzed. Only 33.4% felt gastroenterologists were responsible for MSI/IHC ordering; pathologists were believed most responsible (38.6%). Cost, unfamiliarity interpreting results and unavailable genetic counseling most commonly prevented routine ordering (33.3%, 29.2%, 24.9%, respectively). In multivariable analysis, non-academic and rural settings were associated with cost and genetic counseling barriers. Only 46.1% felt MSI/IHC should always be performed on colonoscopy biopsy. Guideline familiarity predicted whether respondents felt surgical resection should be delayed until results returned given potential effect on ECR decisions. CONCLUSION: Inconsistencies in who is felt should order MSI/IHC may lead to diffusion of responsibility, preventing consistent testing, including preoperatively. Assuring institutional universal testing protocols are in place, with focus on timing of testing, can optimize care. Strategies addressing cost barriers and genomic service availability in rural and non-academic settings can enhance testing. Greater emphasis on guideline familiarity is required. Nature Publishing Group US 2018-09-20 /pmc/articles/PMC6148048/ /pubmed/30237431 http://dx.doi.org/10.1038/s41424-018-0047-y Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Noll, Alan J. Parekh, Parth Zhou, Meijiao Weber, Thomas K. Ahnen, Dennis Wu, Xiao-Cheng Karlitz, Jordan J. Barriers to Lynch Syndrome Testing and Preoperative Result Availability in Early-onset Colorectal Cancer: A National Physician Survey Study |
title | Barriers to Lynch Syndrome Testing and Preoperative Result Availability in Early-onset Colorectal Cancer: A National Physician Survey Study |
title_full | Barriers to Lynch Syndrome Testing and Preoperative Result Availability in Early-onset Colorectal Cancer: A National Physician Survey Study |
title_fullStr | Barriers to Lynch Syndrome Testing and Preoperative Result Availability in Early-onset Colorectal Cancer: A National Physician Survey Study |
title_full_unstemmed | Barriers to Lynch Syndrome Testing and Preoperative Result Availability in Early-onset Colorectal Cancer: A National Physician Survey Study |
title_short | Barriers to Lynch Syndrome Testing and Preoperative Result Availability in Early-onset Colorectal Cancer: A National Physician Survey Study |
title_sort | barriers to lynch syndrome testing and preoperative result availability in early-onset colorectal cancer: a national physician survey study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148048/ https://www.ncbi.nlm.nih.gov/pubmed/30237431 http://dx.doi.org/10.1038/s41424-018-0047-y |
work_keys_str_mv | AT nollalan barrierstolynchsyndrometestingandpreoperativeresultavailabilityinearlyonsetcolorectalcanceranationalphysiciansurveystudy AT jparekhparth barrierstolynchsyndrometestingandpreoperativeresultavailabilityinearlyonsetcolorectalcanceranationalphysiciansurveystudy AT zhoumeijiao barrierstolynchsyndrometestingandpreoperativeresultavailabilityinearlyonsetcolorectalcanceranationalphysiciansurveystudy AT weberthomask barrierstolynchsyndrometestingandpreoperativeresultavailabilityinearlyonsetcolorectalcanceranationalphysiciansurveystudy AT ahnendennis barrierstolynchsyndrometestingandpreoperativeresultavailabilityinearlyonsetcolorectalcanceranationalphysiciansurveystudy AT wuxiaocheng barrierstolynchsyndrometestingandpreoperativeresultavailabilityinearlyonsetcolorectalcanceranationalphysiciansurveystudy AT karlitzjordanj barrierstolynchsyndrometestingandpreoperativeresultavailabilityinearlyonsetcolorectalcanceranationalphysiciansurveystudy |